Cancer treatment could be dramatically improved by an invention at the University of Waterloo to precisely locate the edges of tumors during surgery to remove them.
Researchers have developed soft robotic devices driven by neuromuscular tissue that triggers when stimulated by light – bringing mechanical engineering one step closer to developing autonomous biobots.
In a surprise finding, UT Southwestern researchers report that lowering levels of the hormone leptin can reduce obesity, overeating, and the insulin resistance tied to diabetes – and they have found an antibody that can do that.
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
Scientists at Cold Spring Harbor Laboratory (CSHL) have identified 10 cancer drugs currently in clinical trials that do not work how clinicians thought they would. In identifying what went wrong, experts can now work to improve drug discovery and personalized medicine.